Cogent Biosciences, Inc. Other Comprehensive Income (Loss), Net of Tax
Cogent Biosciences, Inc. (COGT) reported Other Comprehensive Income (Loss), Net of Tax of -$355.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$355.00K.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$770.00K.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $147.00K.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $195.00K, a 82.08% decline year-over-year.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was -$92.00K, a 145.77% decline from fiscal 2024.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $201.00K, a 42.57% decline from fiscal 2023.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $350.00K.
- Cogent Biosciences, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$104.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$355.00K 10-Q · filed 2026-08-10 | -$1.13M 10-Q · filed 2026-08-10 | -$978.00K derived: sum of 3 quarters · filed 2026-08-10 | -$783.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$770.00K 10-Q · filed 2026-05-05 | -$623.00K derived: sum of 2 quarters · filed 2026-05-05 | -$428.00K derived: sum of 3 quarters · filed 2026-05-05 | -$579.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $342.00K derived: sum of 2 quarters · filed 2026-02-17 | $191.00K derived: sum of 3 quarters · filed 2026-08-10 | -$92.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | $195.00K 10-Q · filed 2025-11-07 | $44.00K derived: sum of 2 quarters · filed 2026-08-10 | -$239.00K 10-Q · filed 2025-11-07 | -$688.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$151.00K 10-Q · filed 2026-08-10 | -$434.00K 10-Q · filed 2026-08-10 | -$883.00K derived: sum of 3 quarters · filed 2026-08-10 | $205.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$283.00K 10-Q · filed 2026-05-05 | -$732.00K derived: sum of 2 quarters · filed 2026-05-05 | $356.00K derived: sum of 3 quarters · filed 2026-05-05 | $203.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $639.00K derived: sum of 2 quarters · filed 2026-02-17 | $486.00K derived: sum of 3 quarters · filed 2026-02-17 | $201.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.09M 10-Q · filed 2025-11-07 | $935.00K derived: sum of 2 quarters · filed 2025-11-07 | $650.00K 10-Q · filed 2025-11-07 | $1.07M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$153.00K 10-Q · filed 2025-08-05 | -$438.00K 10-Q · filed 2025-08-05 | -$20.00K derived: sum of 3 quarters · filed 2026-02-17 | -$95.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$285.00K 10-Q · filed 2025-05-06 | $133.00K derived: sum of 2 quarters · filed 2026-02-17 | $58.00K derived: sum of 3 quarters · filed 2026-02-17 | -$55.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $343.00K derived: sum of 2 quarters · filed 2026-02-17 | $230.00K derived: sum of 3 quarters · filed 2026-02-17 | $350.00K 10-K · filed 2026-02-17 |
| 2023-09-30 | -$75.00K 10-Q · filed 2024-11-12 | -$188.00K derived: sum of 2 quarters · filed 2024-11-12 | -$68.00K 10-Q · filed 2024-11-12 | -$9.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$113.00K 10-Q · filed 2024-08-06 | $7.00K 10-Q · filed 2024-08-06 | $66.00K derived: sum of 3 quarters · filed 2025-02-25 | -$97.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $120.00K 10-Q · filed 2024-05-07 | $179.00K derived: sum of 2 quarters · filed 2025-02-25 | $16.00K derived: sum of 3 quarters · filed 2025-02-25 | |
| 2022-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$104.00K derived: sum of 2 quarters · filed 2025-02-25 | -$104.00K 10-K · filed 2025-02-25 | |
| 2022-09-30 | -$163.00K 10-Q · filed 2023-11-07 | -$163.00K 10-Q · filed 2023-11-07 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-26 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 derived: sum of 2 quarters · filed 2021-03-16 | $2.00K derived: sum of 3 quarters · filed 2021-03-16 | $12.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.00K derived: sum of 2 quarters · filed 2020-11-09 | $12.00K 10-Q · filed 2020-11-09 | $24.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $2.00K 10-Q · filed 2020-08-11 | $12.00K 10-Q · filed 2020-08-11 | $24.00K derived: sum of 3 quarters · filed 2020-08-11 | $13.00K derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $10.00K 10-Q · filed 2020-05-11 | $22.00K derived: sum of 2 quarters · filed 2020-05-11 | $11.00K derived: sum of 3 quarters · filed 2020-05-11 | $5.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $1.00K derived: sum of 2 quarters · filed 2020-03-26 | -$5.00K derived: sum of 3 quarters · filed 2020-03-26 | $4.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | -$11.00K 10-Q · filed 2019-11-12 | -$17.00K derived: sum of 2 quarters · filed 2019-11-12 | -$8.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$6.00K 10-Q · filed 2019-08-12 | $3.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $9.00K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $8.00K 10-K · filed 2019-03-28 | |||
| 2017-09-30 | $19.00K 10-Q · filed 2018-11-13 | $12.00K derived: sum of 2 quarters · filed 2018-11-13 | $0.00 derived: sum of 3 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$7.00K 10-Q · filed 2018-08-13 | -$19.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | -$12.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |